Literature DB >> 9772203

The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall.

N G He1, S Awasthi, S S Singhal, M B Trent, P J Boor.   

Abstract

The glutathione transferases (GSTs) are a family of ubiquitous enzymes that catalyze the conjugation of reduced glutathione (GSH) with reactive electrophiles. Rat vascular tissue contains GST isoforms that represent a major cellular defense mechanism against atherogenic alpha,beta-unsaturated aldehydes (Misra et al., Toxicol. Appl. Pharmacol. 133, 27-33, 1995). In this study we examined the role of GSTs in providing protection to cultured neonatal vascular smooth muscle cells (VSMCs) from the alpha,beta-unsaturated carbonyl cardiovascular toxins, allylamine and its metabolite, acrolein. Confluent cultured cells were exposed to 2 to 10 microM allylamine (a cardiovascular toxin that is metabolized in vivo and in vitro by VSMCs to the reactive aldehyde, acrolein) or to acrolein (2-10 microM) for 48 h; dose-cytotoxicity curves were generated utilizing a tetrazolium-dependent cytotoxicity assay. Concommittant treatment with sulfasalazine, an established inhibitor of GST, was found to markedly increase allylamine- or acrolein-induced cytotoxicity, decreasing the LC50 by two- to threefold at 50 to 100 microM sulfasalazine. A clonogenic survival assay in VSMCs exposed to these compounds for 4 h confirmed lethal toxicity and enhanced toxicity following cotreatment with sulfasalazine. Isobologram analysis (which statistically defines the limits of additivity of two independent treatments) showed that the sulfasalazine effect on both allylamine and acrolein cytotoxicity was supraadditive, or synergistic. Sulfasalazine was not cytotoxic to VSMCs in the range of concentrations that augmented acrolein or allylamine cytoxicity; total GST activity was inhibited, however, in a dose-dependent manner in that range. GST purified by GSH-affinity chromatography from pelleted untreated cells gave specific activities and kinetic constants consistent with those previously reported for rat aorta total GSTs. The catalytic efficiency (Kcat/Vm) was found to be much greater for 4-hydroxy-2-nonenal than for 1-chloro-2,4-dinitrobenzene (0.058 vs 0.4 s-1 mM-1). Western blot of purified total GSTs using antibodies against rec-mGSTA4-4 revealed a single band at 25 kDa, confirming the presence of a GST isozyme immunologically similar to rat GST8-8, which is known to utilize alpha,beta-unsaturated carbonyls as preferred substrates. Our data indicate that GSTs are an important defense in the vascular media, protecting blood vessels against alpha,beta-unsaturated carbonyl cardiovascular toxins that are involved in initiating atherosclerotic lesions. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9772203     DOI: 10.1006/taap.1998.8511

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

1.  Adenovirus-mediated overexpression of glutathione-s-transferase mitigates transplant arteriosclerosis in rabbit carotid allografts.

Authors:  Ya Xu; Bin Gong; Yongzhen Yang; Yogesh C Awasthi; Paul J Boor
Journal:  Transplantation       Date:  2010-02-27       Impact factor: 4.939

2.  Acrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells.

Authors:  Kasturi Ranganna; Zivar Yousefipour; Rami Nasif; Frank M Yatsu; Shirlette G Milton; Barbara E Hayes
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

3.  Protection of HepG2 cells against acrolein toxicity by 2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide via glutathione-mediated mechanism.

Authors:  Halley Shah; Adam M Speen; Christina Saunders; Elizabeth A S Brooke; Palanisamy Nallasamy; Hong Zhu; Y Robert Li; Zhenquan Jia
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-11

4.  Effects of Phenelzine Administration on Mitochondrial Function, Calcium Handling, and Cytoskeletal Degradation after Experimental Traumatic Brain Injury.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2018-12-12       Impact factor: 5.269

5.  Aldose reductase regulates acrolein-induced cytotoxicity in human small airway epithelial cells.

Authors:  Umesh C S Yadav; K V Ramana; Satish K Srivastava
Journal:  Free Radic Biol Med       Date:  2013-06-12       Impact factor: 7.376

6.  Endothelial glutathione-S-transferase A4-4 protects against oxidative stress and modulates iNOS expression through NF-kappaB translocation.

Authors:  Yongzhen Yang; Yusong Yang; Ya Xu; Scott D Lick; Yogesh C Awasthi; Paul J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-07       Impact factor: 4.219

7.  A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries.

Authors:  Antonio J Lepedda; Antonio Cigliano; Gian Mario Cherchi; Rita Spirito; Marco Maggioni; Franco Carta; Franco Turrini; Celina Edelstein; Angelo M Scanu; Marilena Formato
Journal:  Atherosclerosis       Date:  2008-07-12       Impact factor: 5.162

8.  N-(2-Aminoethyl) Ethanolamine-Induced Morphological, Biochemical, and Biophysical Alterations in Vascular Matrix Associated With Dissecting Aortic Aneurysm.

Authors:  Zhenping Chen; Ya Xu; Paul Bujalowski; Andres F Oberhauser; Paul J Boor
Journal:  Toxicol Sci       Date:  2015-10-05       Impact factor: 4.849

9.  Effect of N-(2-aminoethyl) ethanolamine on hypertrophic scarring changes in vitro: Finding novel anti-fibrotic therapies.

Authors:  Zhenping Chen; Jianhua Gu; Amina El Ayadi; Andres F Oberhauser; Jia Zhou; Linda E Sousse; Celeste C Finnerty; David N Herndon; Paul J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2018-09-22       Impact factor: 4.219

10.  Investigate the Role of Glutathione S Transferase (GST) Polymorphism in Development of Hypertension in UAE Population.

Authors:  Kosar Hussain; Neveen Salah; Sahar Hussain; Sara Hussain
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.